OQROSign up free
Insider trade

Cytokinetics (CYTK): CEO sold ~$472K

Robert I Blum, CEO at Cytokinetics, sold ~$472K of Cytokinetics shares.

~$472K
Approx. value · 7,500 sh @ $62.88
279K
Holds after · shares reported
Traded
Oct 12, 2026
Filed
Oct 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 18, 2026InsiderOfficer sold ~$265K of CYTK shares in the open market
  2. Aug 31, 2026Insider · 2 peopleInsiders: 2 sales (~$1.2M)
  3. Sep 1, 2026InsiderDirector sold ~$357K of CYTK shares in the open market
  4. Sep 8, 2026InsiderOfficer sold ~$264K of CYTK shares in the open market
  5. Sep 11, 2026InsiderDirector sold ~$75K of CYTK shares in the open market
  6. Sep 14, 2026InsiderCEO sold ~$551K of CYTK shares in the open market
  7. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$6.9M)
  8. Sep 22, 2026InsiderOfficer sold ~$239K of CYTK shares in the open market
  9. Sep 28, 2026InsiderCEO sold ~$491K of CYTK shares in the open market
  10. Sep 29, 2026CongressDisclosed purchase of CYTK — reported range $1,001 - $15,000
  11. Oct 6, 2026InsiderOfficer sold ~$215K of CYTK shares in the open market
  12. Oct 12, 2026 · this disclosureInsiderCEO sold ~$472K of CYTK shares in the open market

What came next

  1. Oct 20, 2026InsiderOfficer sold ~$224K of CYTK shares in the open market
  2. Nov 2, 2026InsiderCEO sold ~$471K of CYTK shares in the open market
  3. Nov 3, 2026InsiderOfficer sold ~$220K of CYTK shares in the open market
  4. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
  5. Nov 9, 2026Insider · 1 personInsiders: 2 sales (~$274K)
  6. Nov 10, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.1%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 21 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by Robert I Blum, President & CEO

The full history of Robert I Blum, President & CEO is on the profile page.

How this filing works

Explore the data

Other disclosures at Cytokinetics

Everything OQRO holds on this company is on its CYTK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data